Table 1 Demographic and clinical data of patients with non-metastatic and metastatic GC
From: The E2F3/miR-125a/DKK3 regulatory axis promotes the development and progression of gastric cancer
|  | Non-metastatic GC (n = 30) | Metastatic GC (n = 30) |
|---|---|---|
Average age (years) | 53 ± 7.28 | 57 ± 6.35 |
Sex | ||
 Female | 10 | 16 |
 Male | 20 | 14 |
Clinical staging | ||
 I | 9 | 5 |
 II | 11 | 9 |
 III | 8 | 13 |
 IV | 2 | 3 |
Grade | ||
 Well-differentiated | 15 | 14 |
 Moderately-differentiated | 15 | 12 |
 Poorly-differentiated | 0 | 4 |